F. Schubert

发表

Canadian Guidelines for Economic Evaluation of Pharmaceuticals

George W. Torrance, Peter Tugwell, Allan Detsky, 1996, PharmacoEconomics.

Information Barriers to the Implementation of Economic Evaluations in Japan

M. Drummond, N. Ikegami, S. Fukuhara, 2012, PharmacoEconomics.

Why Has the Use of Health Economic Evaluation in Japan Lagged Behind that in Other Developed Countries?

M. Drummond, N. Ikegami, S. Fukuhara, 2012, PharmacoEconomics.

Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics.

A. Detsky, P. Tugwell, G. Torrance, 1996, PharmacoEconomics.

Canadian Coordinating Office for Health Technology Assessment Office Canadien de Coordination de l’Évaluation des Technologies de la Santé GUIDELINES FOR ECONOMIC EVALUATION OF PHARMACEUTICALS: CANADA

Coordinator, P. Tugwell, G. Torrance, 1997 .

Commentary on “Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.” A Canadian perspective

C. Patterson, S. Gauthier, J. Soucy, 2011, Alzheimer's & Dementia.

The Development and Use of Quality-of-Life Measures to Evaluate Health Outcomes in Japan

M. Drummond, N. Ikegami, S. Fukuhara, 2012, PharmacoEconomics.

Canada's new guidelines for the economic evaluation of pharmaceuticals.

D Menon, G W Torrance, F. Schubert, 1996, Medical care.

HEALTH TECHNOLOGY ASSESSMENT

F. Schubert, 2002, International Journal of Technology Assessment in Health Care.